Last edition
News about
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
Evotec has reported advancement in its preclinical neuroscience collaboration with Bristol Myers Squibb, securing a payment of USD 25 Million to support the continued development of jointly pursued therapeutic programmes.
Bahrain's sovereign fund partners with SandboxAQ to accelerate AI-driven drug discovery
Bahrain’s sovereign wealth fund, Mumtalakat, has entered into a strategic partnership with SandboxAQ, a USA-based company specialising in artificial intelligence and quantum technologies, to fast-track drug discovery and build biotech assets valued at up to USD 1 billion.
KP Group and Fabtech Group Partner to Build Green Infrastructure for Global Life Sciences Projects
Under the partnership, all projects executed by Fabtech Group—including conventional and stick-built—will be powered by clean, renewable energy supplied by KP Group.
Sai Life Sciences Set to Double Process R&D Capacity with New Facility in Hyderabad
The upcoming Process R&D Block at Sai Life Sciences will cover 100,000 sq. ft. across five floors, featuring 140 process chemistry fume hoods, an integrated satellite analytical lab, and dedicated peptide and oligo labs, supported by a 25,000 sq. ft. central analytical facility.
Lupin Expands US Footprint with New Corporate Offices in Bridgewater, New Jersey
Lupin has inaugurated its new corporate offices at 100 Somerset Corporate Blvd, Bridgewater, New Jersey, expanding its presence in the state where it already operates manufacturing and research facilities.
Biotech Fluidics Launches Miniature Flat-Bottom Port Fittings for Microfluidic Systems
Biotech Fluidics has introduced a new range of miniature flat-bottom port fittings designed for life science microfluidic instruments that handle low liquid volumes in limited space environments.
Lilly's Omvoh Shows Early, Sustained Relief in Bowel Urgency for Ulcerative Colitis
Lilly’s Phase 3b LUCENT-URGE results show that Omvoh (mirikizumab-mrkz) provides early and sustained improvements in bowel urgency in ulcerative colitis. The study is the first in inflammatory bowel disease to assess urgency across severity, frequency, and stool deferral time.
Akums Expands Global Footprint with New Pharmaceutical Facility in Zambia
Akums Drugs & Pharmaceuticals has held the groundbreaking ceremony of its first overseas manufacturing facility in Zambia, marking a major milestone in its global expansion journey.
CDSCO lists 1,700 BIS standards to strengthen medical device compliance and hospital planning
The Central Drugs Standard Control Organisation (CDSCO) has released a comprehensive list of around 1,700 standards developed under the Medical Equipment and Hospital Planning Division (MHD) of the Bureau of Indian Standards (BIS).
Health Canada Grants Authorisation for Leqembi (Lecanemab)
BioArctic has the right to commercialise Leqembi in the Nordic region together with Eisai and the two companies are preparing for a joint commercialisation in the region.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy